Skip to main content
. 2019 May 28;127(5):057011. doi: 10.1289/EHP3849

Table 3.

Results from gene set enrichment analysis of hallmark gene set collection (n=54 sets) among the urinary arsenic–associated CpGs identified in the HEALS discovery analysis (n=396) and meta-analysis of HEALS and BEST (n=796).

Top 500 arsenic-associated CpGsa Arsenic-associated CpGs below FDR<0.05b
n Genes p Genes p
HEALS
 Angiogenesis 36 3 6.4×103
 Cholesterol homeostasis 74 4 1.2×102
TNFα signaling via NFκB 200 7 2.1×102
META-ANALYSIS
 Allograft rejection 200 9 2.2×103 4 1.9×102
PI3K/AKT/mTOR 105 6 9.8×103 3 2.2×102
 Reactive oxygen species pathway 49 3 1.4×102 2 9.1×103
 Inflammatory response 200 6 2.9×102 3 4.4×102
TNFα signaling via NFκB 200 7 4.1×102 4 3.1×102
 Estrogen response early 200 10 1.1×102
 UV response up-regulated 158 7 1.4×102
MTORC1 signaling 200 4 1.8×102
 Oxidative phosphorylation 200 3 3.1×102
MYC targets V1 200 3 4.7×102
 Apical junction 200 4 4.8×102

Note: Gene annotations for arsenic-associated CpGs are provided as gene set input for the gometh function. Results are presented for hallmark gene sets (n=54 sets) with at least two genes from arsenic-associated CpG gene set and enrichment (p<0.05). Background gene set for 450K is 19,246 genes, and EPIC is 23,234 genes. The table reports total number of genes in set (n), genes identified in pathway from CpG gene set, and p-value from CpG bias-corrected hypergeometric test. —, no data; BEST, Bangladesh Vitamin E and Selenium Trial; FDR, false discovery rate; HEALS, Health Effects of Arsenic Longitudinal Study; TNFα, tumor necrosis factor α.

a

Top 500 arsenic-associated CpGs, annotated to 348 unique genes in the HEALS discovery analysis (EPIC array), 338 unique genes in the meta-analysis (450K array).

b

Arsenic-associated CpGs (FDR<0.05), annotated to 21 unique genes in the discovery analysis, 153 unique genes in the meta-analysis.